Reveal Biosciences is creating a new generation of data powered pathology to enhance research and improve global healthcare.
Cancer has impacted the lives of many of our friends and family. Reveal was founded in 2012 by Claire Weston and Casey Laris with a vision towards pathology driven by data. Our team is creating artificial intelligence technologies for whole slide pathology images that increase accuracy, reproducibility and scale. If the technology we’re building today had been available 15 years ago, a cancer misdiagnosis in Casey’s own family would likely have been caught. We see that by taking a quantitative approach, the data generated by our tools benefits preclinical research, clinical trials, and ultimately patients.
We are proud to partner with the following organizations
Latest research, in the news, or at events.
LAKE FOREST, CA, March 1st, 2022 – CellCarta, a global provider of precision medicine services, announced today the launch of imageDx PRISM to significantly advance the spatial biology data
Reveal Biosciences Creates A New Artificial Intelligence Approach to Spatial Genomics in Partnership with QuantumCyte
The partnership paves way for the integration of AI-driven spatial genomics with a unique cloud-based platform (SAN DIEGO, Jan. 19, 2021) — Reveal Biosciences, Inc., a leader in AI